Trials / Completed
CompletedNCT01202747
Evaluation of Screening Methods for Treatment of Meibomian Gland Dysfunction
Pilot Study for Evaluation of LipiFlow Screening Methods
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- TearScience, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective is to evaluate the feasibility of using additional screening methods to optimize effectiveness outcomes with the LipiFlow System for application of heat and pressure therapy in adult patients with chronic cystic conditions of the eyelids, including meibomian gland dysfunction, also known as evaporative dry eye or lipid deficiency dry eye, and chalazia. The screening methods include diagnostic expression of the meibomian glands and interferometry assessment of the tear film.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | LipiFlow System | In-office treatment for meibomian gland dysfunction |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2011-01-01
- Completion
- 2011-01-01
- First posted
- 2010-09-16
- Last updated
- 2011-12-06
- Results posted
- 2011-12-06
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01202747. Inclusion in this directory is not an endorsement.